<code id='BC7BCBC803'></code><style id='BC7BCBC803'></style>
    • <acronym id='BC7BCBC803'></acronym>
      <center id='BC7BCBC803'><center id='BC7BCBC803'><tfoot id='BC7BCBC803'></tfoot></center><abbr id='BC7BCBC803'><dir id='BC7BCBC803'><tfoot id='BC7BCBC803'></tfoot><noframes id='BC7BCBC803'>

    • <optgroup id='BC7BCBC803'><strike id='BC7BCBC803'><sup id='BC7BCBC803'></sup></strike><code id='BC7BCBC803'></code></optgroup>
        1. <b id='BC7BCBC803'><label id='BC7BCBC803'><select id='BC7BCBC803'><dt id='BC7BCBC803'><span id='BC7BCBC803'></span></dt></select></label></b><u id='BC7BCBC803'></u>
          <i id='BC7BCBC803'><strike id='BC7BCBC803'><tt id='BC7BCBC803'><pre id='BC7BCBC803'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:631
          Cholesterol
          APStock

          Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

          Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed  reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

          advertisement

          The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          Biden administration opens offers in Medicare drug price negotiations
          Biden administration opens offers in Medicare drug price negotiations

          ScottOlson/GettyImagesWASHINGTON —TheBidenadministrationismakingitsopeningofferstopharmaceuticalcomp

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          FDA early review: GLP

          SarahSilbiger/GettyImagesApreliminaryevaluationbytheFoodandDrugAdministrationdidnotfindevidencethatG